Genes, chromatin, and breast cancer: an epigenetic tale.

作者: Lawrence M. Mielnicki , Harold L. Asch , Bonnie B. Asch

DOI: 10.1023/A:1011356623442

关键词:

摘要: The production of heritable changes in gene expression is the driving force development and progression breast cancer. Such can result from mutations or epigenetic events such as hypermethylation DNA hypoacetylation histones. Histone acetylation methylation are major determinants chromatin structure, structure a primary regulator transcription. Cancer cells frequently contain both mutated genes with altered due to one more mechanisms. This review describes that disrupt normal architecture modify key cancer cells. structural integrity latter usually intact, but their has been substantially promoter region deacetylation histones interact Genes affected by cancers include HoxA5, p21WAF, gelsolin, BRCA1, BRCA2, E-cadherin, steroid hormone receptors, retinoic acid receptor II. Because these modifications reversible treatment certain drugs, they represent vulnerabilities cell be exploited novel targets for new prevention therapeutic strategies.

参考文章(126)
Kenneth K. Chan, Ray Bakhtiar, Chun Jiang, Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS Investigational New Drugs. ,vol. 15, pp. 195- 206 ,(1997) , 10.1023/A:1005847703624
Elizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen, James G. Herman, Stephen B. Baylin, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nature Genetics. ,vol. 21, pp. 103- 107 ,(1999) , 10.1038/5047
Cindy A. Wilson, Lillian Ramos, Maria R. Villaseñor, Karl H. Anders, Michael F. Press, Kathy Clarke, Beth Karlan, Jun-Jie Chen, Ralph Scully, David Livingston, Robert H. Zuch, Michael H. Kanter, Sylvan Cohen, Frank J. Calzone, Dennis J. Slamon, Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas Nature Genetics. ,vol. 21, pp. 236- 240 ,(1999) , 10.1038/6029
Venu Raman, Shelby A. Martensen, David Reisman, Ella Evron, Ward F. Odenwald, Elizabeth Jaffee, Jeffrey Marks, Saraswati Sukumar, Compromised HOXA5 function can limit p53 expression in human breast tumours Nature. ,vol. 405, pp. 974- 978 ,(2000) , 10.1038/35016125
Joseph F. Costello, Mitchel S. Berger, H-J. Su Huang, Webster K. Cavenee, Silencing of p16/CDKN2 Expression in Human Gliomas by Methylation and Chromatin Condensation Cancer Research. ,vol. 56, pp. 2405- 2410 ,(1996)
William B. Isaacs, Stephen B. Baylin, Nancy E. Davidson, Jeremy R. Graff, James G. Herman, Rena G. Lapidus, Paula M. Pitha, Rosa Xu, Hemi Chopra, David F. Jarrard, E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas Cancer Research. ,vol. 55, pp. 5195- 5199 ,(1995)
David S. Salomon, Herbert L. Cooper, Eva M. Valverius, Basudev Bhattacharya, Gaddamanugu L. Prasad, Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Research. ,vol. 50, pp. 2105- 2112 ,(1990)
Richard J. Lin, Laszlo Nagy, Satoshi Inoue, Wenlin Shao, Wilson H. Miller, Ronald M. Evans, Role of the histone deacetylase complex in acute promyelocytic leukaemia Nature. ,vol. 391, pp. 811- 814 ,(1998) , 10.1038/35895
Peter A Jones, Peter W Laird, Cancer-epigenetics comes of age Nature Genetics. ,vol. 21, pp. 163- 167 ,(1999) , 10.1038/5947